Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026)
Si-Bone's (SIBN) quarterly Cash from Investing Activities came in at -$6.2 million in Q1 2026, down 158.63% year-on-year from $10.6 million in Q1 2025, and down 147.84% quarter-over-quarter from $13.0 million in Q4 2025.
Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Si-Bone's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 158.63% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$12.7 million, a 175.13% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 67.04% from the prior year.
- Cash from Investing Activities declined to -$6.2 million in Q1 2026 per SIBN's latest filing, from $13.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $13.0 million in Q4 2025 and bottomed at -$54.9 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is $2.3 million (2023), against an average of -$3.1 million.
- Across the five-year window, Cash from Investing Activities tumbled 21349.44% in 2023 and surged 200.35% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $89000.0 in 2022, then tumbled by 21349.44% to -$18.9 million in 2023, then soared by 122.93% to $4.3 million in 2024, then jumped by 200.35% to $13.0 million in 2025, then tumbled by 147.84% to -$6.2 million in 2026.
- Per Business Quant, the three latest SIBN Cash from Investing Activities figures stand at -$6.2 million (Q1 2026), $13.0 million (Q4 2025), and -$10.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | -6.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.23 Mn |
| Mar 31, 2026 | -6.23 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | -18.91 Mn |
| Dec 31, 2023 | -18.91 Mn |